Aptorum Group Limited Announces Up To $6 Million Registered Direct Offering

Core Viewpoint - Aptorum Group Limited has announced a registered direct offering of 1,000,000 Class A ordinary shares at a price of $2.00 per share, with potential additional gross proceeds of up to $4 million from unregistered warrants [1][3]. Group 1: Offering Details - The offering is expected to generate gross proceeds of $2 million before deducting fees and expenses [3]. - The company will issue unregistered warrants to purchase up to 2,000,000 Class A ordinary shares at an exercise price of $2.00 per share, which will be exercisable upon issuance and expire in twenty-four months [1][3]. - The closing of the offering is anticipated to occur around October 14, 2025, subject to customary closing conditions [1]. Group 2: Use of Proceeds - The net proceeds from the offering will be used to fund expenses related to the merger agreement between Aptorum and DiamiR Biosciences Corp., as well as for general working capital for both companies pending the merger's closing [3]. Group 3: Regulatory Information - The ordinary shares are being offered under a "shelf" registration statement that was declared effective by the SEC on January 19, 2023 [4]. - The unregistered warrants are being offered in a private placement under Section 4(a)(2) of the Securities Act and have not been registered under applicable securities laws [5].